EA201692531A1 - Способы лечения инфекций - Google Patents

Способы лечения инфекций

Info

Publication number
EA201692531A1
EA201692531A1 EA201692531A EA201692531A EA201692531A1 EA 201692531 A1 EA201692531 A1 EA 201692531A1 EA 201692531 A EA201692531 A EA 201692531A EA 201692531 A EA201692531 A EA 201692531A EA 201692531 A1 EA201692531 A1 EA 201692531A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
days
treating infections
treating
risk
Prior art date
Application number
EA201692531A
Other languages
English (en)
Inventor
Даньпин Ли
Скотт Дж. Хопкинс
Джеррод Лонгкор
Original Assignee
Мелинта Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54868662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201692531(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Мелинта Терапьютикс, Инк. filed Critical Мелинта Терапьютикс, Инк.
Publication of EA201692531A1 publication Critical patent/EA201692531A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Molecular Biology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к способам лечения, профилактики или снижения риска микробных инфекций, минимизируя при этом нежелательные побочные желудочно-кишечные эффекты, с использованием двухстадийного режима дозирования, включающего внутривенное введение от приблизительно 1 до приблизительно 7 дней, с последующим пероральным введением в течение от приблизительно 1 до приблизительно 14 дней антимикробного средства.
EA201692531A 2014-06-20 2015-06-19 Способы лечения инфекций EA201692531A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462014790P 2014-06-20 2014-06-20
US201462034468P 2014-08-07 2014-08-07
PCT/US2015/036699 WO2015196076A1 (en) 2014-06-20 2015-06-19 Methods for treating infections

Publications (1)

Publication Number Publication Date
EA201692531A1 true EA201692531A1 (ru) 2017-05-31

Family

ID=54868662

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201692531A EA201692531A1 (ru) 2014-06-20 2015-06-19 Способы лечения инфекций

Country Status (17)

Country Link
US (2) US20150366858A1 (ru)
EP (1) EP3157633A4 (ru)
JP (1) JP2017518354A (ru)
CN (1) CN106687179A (ru)
AU (1) AU2015276911A1 (ru)
BR (1) BR112016029896A2 (ru)
CA (1) CA2952955A1 (ru)
CL (1) CL2016003271A1 (ru)
EA (1) EA201692531A1 (ru)
EC (1) ECSP16095557A (ru)
IL (1) IL249616A0 (ru)
MX (1) MX2016017348A (ru)
PH (1) PH12016502547A1 (ru)
SV (1) SV2016005348A (ru)
TW (1) TW201605447A (ru)
UY (1) UY36183A (ru)
WO (1) WO2015196076A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693695A (zh) * 2014-11-24 2016-06-22 重庆医药工业研究院有限责任公司 一种德拉沙星葡甲胺盐的晶型及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
EP3957632A1 (en) * 2004-10-08 2022-02-23 AbbVie Inc. Meglumine salt and crystalline forms thereof of a drug (delafloxacin)
EP2286800A1 (en) * 2005-04-11 2011-02-23 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN1943561A (zh) * 2006-08-23 2007-04-11 北京阜康仁生物制药科技有限公司 普卢利沙星口腔崩解片及其制备方法
CN102164912B (zh) * 2008-09-24 2015-08-19 麦林塔医疗有限公司 制备喹诺酮类化合物的工艺
CA2743419C (en) * 2008-11-15 2017-02-14 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
WO2010096551A2 (en) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
EP2969004A4 (en) * 2013-03-15 2016-09-21 Melinta Therapeutics Inc METHOD FOR THE TREATMENT OF INFECTIONS IN OVERWEIGHT AND ADIPOSIVE PATIENTS USING ANTIBIOTICS

Also Published As

Publication number Publication date
CA2952955A1 (en) 2015-12-23
WO2015196076A1 (en) 2015-12-23
TW201605447A (zh) 2016-02-16
US20170368055A1 (en) 2017-12-28
IL249616A0 (en) 2017-02-28
BR112016029896A2 (pt) 2017-08-22
ECSP16095557A (es) 2017-03-31
EP3157633A1 (en) 2017-04-26
UY36183A (es) 2016-01-29
JP2017518354A (ja) 2017-07-06
MX2016017348A (es) 2017-04-06
CN106687179A (zh) 2017-05-17
US20150366858A1 (en) 2015-12-24
AU2015276911A1 (en) 2017-01-12
AU2015276911A2 (en) 2018-04-26
SV2016005348A (es) 2017-03-02
CL2016003271A1 (es) 2017-08-04
PH12016502547A1 (en) 2017-04-10
EP3157633A4 (en) 2018-02-21

Similar Documents

Publication Publication Date Title
PH12016501750A1 (en) Human plasma kallikrein inhibitors
TW201613887A (en) Antiproliferative compounds and methods of use thereof
PH12018500065A1 (en) Oxysterols and methods of use thereof
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
NZ730809A (en) Methods for treating filoviridae virus infections
PH12018500061A1 (en) Oxysterols and methods of use thereof
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
EA201790442A1 (ru) Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae
BR112018074985A2 (pt) composições antibacterianas
MX2017012073A (es) Compuestos de minociclina para biodefensas.
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
PH12018500358A1 (en) Compounds for use in an antibacterial applications
WO2015001541A3 (en) Pharmaceutical film composition
WO2016020408A3 (en) Compounds for preventing ototoxicity
PH12016502547A1 (en) Methods for treating infections
PH12016502548A1 (en) Antimicrobial compositions with effervescent agents
EA201792265A1 (ru) Способы лечения сердечно-сосудистых заболеваний
CR20160591A (es) Metodos para tratar infecciones
BR112016024236A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
AR115865A2 (es) Compuestos terapéuticos
MX2015003939A (es) Combinacion y composicion farmaceutica que contiene un antimicrobiano y un antimicotico.
TH171202A (th) สารประกอบและวิธีการสำหรับการรักษาการติดเชื้อแบคทีเรีย
EA201390764A1 (ru) Фармацевтические композиции